BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma

NCT04617704 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: GC012F injection

Sponsor

Shanghai Changzheng Hospital

Collaborators

[object Object]